
|Podcasts|July 29, 2022
Pharmacy Focus: Psychedelic Pharmacy - Investigating Ketamine for Chronic Pain Management, Addiction Treatment
This month, we spoke with Tiago Reis Marques, MD, PhD, CEO of Pasithea Therapeutics, about ketamine and the future of the opioid epidemic.
Advertisement
This month, we spoke with Tiago Reis Marques, MD, PhD, CEO of Pasithea Therapeutics, about how investigative psychedelic treatments could help treat both chronic pain as well as addiction, and what this could mean for the future of the opioid epidemic.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Announces Recall 580,000 Bottles of Prazosin Over Potential Carcinogenic Impurity
2
Regular Melatonin Supplementation May Hide Hidden Heart Complications
3
COVID-19 During Pregnancy Raises Neurodevelopmental Risks in Children
4
From Type 1 to Type 2 and Beyond: Navigating the Landscape of Diabetes
5














































































































































































































